A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria

被引：0

作者：

Fiona Macintyre

Yeka Adoke

Alfred B. Tiono

Tran Thanh Duong

Ghyslain Mombo-Ngoma

Marielle Bouyou-Akotet

Halidou Tinto

Quique Bassat

Saadou Issifou

Marc Adamy

Helen Demarest

Stephan Duparc

Didier Leroy

Bart E. Laurijssens

Sophie Biguenet

Afizi Kibuuka

Antoinette Kitoto Tshefu

Melnick Smith

Chanelle Foster

Illse Leipoldt

Peter G. Kremsner

Bui Quang Phuc

Alphonse Ouedraogo

Michael Ramharter

机构：

[1] Medicines for Malaria Venture,Infectious Diseases Research Collaboration

[2] Tororo Hospital,Universite des Sciences de la Sante Gabon, Département de Parasitology, Malaria Clinical and Operational Research Unit

[3] Centre National de Recherche et de Formation sur le Paludisme,Centre de Recherche du Centre Hospitalier de Mont Amba, Kinshasa School of Public Health

[4] National Institute of Malariology,Department of Medicine I, Division of Infectious Diseases

[5] Parasitology and Entomology,undefined

[6] Centre de Recherches Médicales de Lambaréné,undefined

[7] Institut für Tropenmedizin,undefined

[8] Universität Tübingen,undefined

[9] Melen Hospital,undefined

[10] Institut de Recherche en Sciences de la Santé – Unité de Recherche Clinique de Nanoro,undefined

[11] ISGlobal,undefined

[12] Barcelona Ctr. Int. Health Res. (CRESIB),undefined

[13] Hospital Clínic - Universitat de Barcelona,undefined

[14] Centro de Investigação em Saúde de Manhiça (CISM),undefined

[15] ICREA,undefined

[16] Pediatric Infectious Diseases Unit,undefined

[17] Pediatrics Department,undefined

[18] Hospital Sant Joan de Déu (University of Barcelona),undefined

[19] Universidad Europea de Madrid,undefined

[20] Centre de Recherche sur le Paludisme Associé à la Grossesse et l’Enfance,undefined

[21] Faculte Des Sciences De La Sante,undefined

[22] BEL Pharm Consulting,undefined

[23] University of Kinshasa,undefined

[24] QuintilesIMS,undefined

[25] Department: Biostatistics,undefined

[26] Medical University of Vienna,undefined

[27] Bernhard Nocht Hospital for Tropical Diseases,undefined

[28] Bernhard Nocht Institute for Tropical Medicine and University Medical Center Hamburg-Eppendorf,undefined

来源：

BMC Medicine | / 15卷

关键词：

Artefenomel; OZ439; Piperaquine; Single dose combination treatment; Pharmacokinetics; Dose–response; modelling and simulation; Phase II B; Uncomplicated ; malaria; Children;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial
Gosling, Roly D.
Gesase, Samwel
Mosha, Jacklin F.
Carneiro, Ilona
Hashim, Ramadhan
Lemnge, Martha
Mosha, Frank W.
Greenwood, Brian
Chandramohan, Daniel
LANCET, 2009, 374 (9700) : 1521 - 1532
[42] Phase 1 randomized double-blind safety an immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
Stoute, Jose A.
Gombe, Joash
Withers, Mark R.
Siangla, Joram
McKinney, Denise
Onyango, Melanie
Cummings, James F.
Milmane, Jessica
Tucker, Kathryn
Soisson, Lorraine
Stewart, V. Ann
Lyon, Jeffrey A.
Angov, Evelina
Leach, Amanda
Cohen, Joe
Kester, Kent E.
Ockenhouse, Christian F.
Holland, Carolyn A.
Diggs, Carter L.
Wittes, Janet
Heppner, D. Gray, Jr.
VACCINE, 2007, 25 (01) : 176 - 184
[43] Efficacy and safety of Qinxiang Qingjie oral solution for the treatment of influenza in children: a randomized, double-blind, multicenter clinical trial
Hu, Siyuan
Ma, Rong
Shen, Kunling
Xin, Deli
Li, Xinmin
Xu, Baoping
Zhao, Xiaobing
Feng, Ziwei
Yan, Yongbin
Xue, Zheng
Zhang, Baoqing
Li, Xueming
Zheng, Yanmei
Zhou, Hongxia
Wu, Liqun
Yang, Lili
Xu, Hua
Shao, Rongchang
Yin, Yong
Zhong, Chengliang
Li, Han
Cai, Qiuhan
Xu, Yaqian
TRANSLATIONAL PEDIATRICS, 2022, 11 (06) : 987 - +
[44] Efficacy and safety of the six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in adolescents and adults:: A pooled analysis of individual patient data from randomized clinical trials
Mueller, Edgar A.
van Vugt, Michele
Kirch, Wilhelm
Andriano, Kim
Hunt, Philip
de Palacios, Patricia Ibarra
ACTA TROPICA, 2006, 100 (1-2) : 41 - 53
[45] Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA : a phase 3, double-blind, randomised, placebo-controlled multicentre trial
Lipton, Richard B.
Croop, Robert
Stock, David A.
Madonia, Jennifer
Forshaw, Micaela
Lovegren, Meghan
Mosher, Linda
Coric, Vladimir
Goadsby, Peter J.
LANCET NEUROLOGY, 2023, 22 (03)
[46] Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
Bronner P. Gonçalves
Alfred B. Tiono
Alphonse Ouédraogo
Wamdaogo M. Guelbéogo
John Bradley
Issa Nebie
Débé Siaka
Kjerstin Lanke
Alice C. Eziefula
Amidou Diarra
Helmi Pett
Edith C. Bougouma
Sodiomon B. Sirima
Chris Drakeley
Teun Bousema
BMC Medicine, 14
[47] A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naive adults
Cummings, J. F.
Polhemus, M. E.
Kester, K. E.
Ockenhouse, C. F.
Gasser, R. A.
Coyne, P.
Wortmann, G.
Nielsen, R. K.
Schaecher, K.
Holland, C. A.
Krzych, U.
Tornieporth, N.
Soisson, L. A.
Angov, E.
Heppner, D. G.
VACCINE, 2024, 42 (12) : 3066 - 3074
[48] A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms ("KHENERGYC")
Smeitink, Jan
van Maanen, Rob
de Boer, Lonneke
Ruiterkamp, Gerrit
Renkema, Herma
BMC NEUROLOGY, 2022, 22 (01)
[49] A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms (“KHENERGYC”)
Jan Smeitink
Rob van Maanen
Lonneke de Boer
Gerrit Ruiterkamp
Herma Renkema
BMC Neurology, 22
[50] Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study
Ogutu, Bernhards R.
Onyango, Kevin O.
Koskei, Nelly
Omondi, Edgar K.
Ongecha, John M.
Otieno, Godfrey A.
Obonyo, Charles
Otieno, Lucas
Eyase, Fredrick
Johnson, Jacob D.
Omollo, Raymond
Perkins, Douglas J.
Akhwale, Willis
Juma, Elizabeth
MALARIA JOURNAL, 2014, 13

← 1 2 3 4 5 →